Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07151729 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Use of Anodal tDCS to Enhance Upper Limb Recovery in Stroke

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 3, 2025 (before its estimated September 15, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Tan Tock Seng Hospital
37 trials monitored
See 4 trials at risk
Stroke
3,531 trials monitored
See 153 trials at risk
This will be a randomized, blinded, sham-controlled trial. The medical device used, Soterix Medical 1x1 tDCS stimulator, is capable of delivering either real or sham tDCS and has been used in many randomised controlled trials in stroke patients. 50 patients with subacute stroke and severe upper limb weakness within 8 weeks of stroke on transfer to TTSH stroke rehab wards will be recruited over a period of 10 months. Recruited patients will be randomized into the intervention and control arms in a 1:1 ratio.
Trial Details
NCT Number NCT07151729
Lead Sponsor Tan Tock Seng Hospital
Collaborators: Ng Teng Fong Healthcare Innovation Programme
Conditions
(from sponsor)		 Stroke
Related terms Stroke
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov